56 related articles for article (PubMed ID: 18350355)
1. Genetic variation in imprinted genes is associated with risk of late-onset Alzheimer's disease.
Chaudhry M; Wang X; Bamne MN; Hasnain S; Demirci FY; Lopez OL; Kamboh MI
J Alzheimers Dis; 2015; 44(3):989-94. PubMed ID: 25391383
[TBL] [Abstract][Full Text] [Related]
2. A Multi-Marker Genetic Association Test Based on the Rasch Model Applied to Alzheimer's Disease.
Wang W; Mandel J; Bouaziz J; Commenges D; Nabirotchkine S; Chumakov I; Cohen D; Guedj M;
PLoS One; 2015; 10(9):e0138223. PubMed ID: 26379234
[TBL] [Abstract][Full Text] [Related]
3. Focusing on cyclin-dependent kinases 5: A potential target for neurological disorders.
Tian Z; Feng B; Wang XQ; Tian J
Front Mol Neurosci; 2022; 15():1030639. PubMed ID: 36438186
[TBL] [Abstract][Full Text] [Related]
4. Exploring Kinase Inhibition Properties of 9
Loidreau Y; Dubouilh-Benard C; Nourrisson MR; Loaëc N; Meijer L; Besson T; Marchand P
Pharmaceuticals (Basel); 2020 May; 13(5):. PubMed ID: 32397570
[TBL] [Abstract][Full Text] [Related]
5. Blood-Based Kinase Assessments in Alzheimer's Disease.
Hugon J; Mouton-Liger F; Cognat E; Dumurgier J; Paquet C
Front Aging Neurosci; 2018; 10():338. PubMed ID: 30487744
[TBL] [Abstract][Full Text] [Related]
6. Cyclin-dependent kinase 5 promotes pancreatic β-cell survival via Fak-Akt signaling pathways.
Daval M; Gurlo T; Costes S; Huang CJ; Butler PC
Diabetes; 2011 Apr; 60(4):1186-97. PubMed ID: 21378178
[TBL] [Abstract][Full Text] [Related]
7. Cancer and neurodegeneration: between the devil and the deep blue sea.
Plun-Favreau H; Lewis PA; Hardy J; Martins LM; Wood NW
PLoS Genet; 2010 Dec; 6(12):e1001257. PubMed ID: 21203498
[TBL] [Abstract][Full Text] [Related]
8. SORL1 haplotypes modulate risk of Alzheimer's disease in Chinese.
Tan EK; Lee J; Chen CP; Teo YY; Zhao Y; Lee WL
Neurobiol Aging; 2009 Jul; 30(7):1048-51. PubMed ID: 18063222
[TBL] [Abstract][Full Text] [Related]
9. Genetic Association of CHAT rs3810950 and rs2177369 Polymorphisms with the Risk of Alzheimer's Disease: A Meta-Analysis.
Liu Y; Chen Q; Liu X; Dou M; Li S; Zhou J; Liu H; Wu Y; Huang Z
Biomed Res Int; 2016; 2016():9418163. PubMed ID: 27597977
[TBL] [Abstract][Full Text] [Related]
10. Cyclin-dependent kinase 5 is associated with risk for Alzheimer's disease in a Dutch population-based study.
Arias-Vásquez A; Aulchenko YS; Isaacs A; van Oosterhout A; Sleegers K; Hofman A; van Broeckhoven C; Oostra BA; Breteler M; van Duijn CM
J Neurol; 2008 May; 255(5):655-62. PubMed ID: 18350355
[TBL] [Abstract][Full Text] [Related]
11. No association of CDK5 genetic variants with Alzheimer's disease risk.
Vázquez-Higuera JL; Mateo I; Sánchez-Juan P; Rodríguez-Rodríguez E; Infante J; Berciano J; Combarros O
BMC Med Genet; 2009 Jul; 10():68. PubMed ID: 19615060
[TBL] [Abstract][Full Text] [Related]
12. Association of cyclin-dependent kinase 5 and neuronal activators p35 and p39 complex in early-onset Alzheimer's disease.
Rademakers R; Sleegers K; Theuns J; Van den Broeck M; Bel Kacem S; Nilsson LG; Adolfsson R; van Duijn CM; Van Broeckhoven C; Cruts M
Neurobiol Aging; 2005; 26(8):1145-51. PubMed ID: 15917097
[TBL] [Abstract][Full Text] [Related]
13. Gene variations in GSTM3 are a risk factor for Alzheimer's disease.
Hong GS; Heun R; Jessen F; Popp J; Hentschel F; Kelemen P; Schulz A; Maier W; Kölsch H
Neurobiol Aging; 2009 May; 30(5):691-6. PubMed ID: 17904251
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
